On The Fly
| ShowHide Related Items >><< - 01/14/21
- Aphria jumps 6.5% to $10.65 after posting strong Q2 results
- 01/14/21
- Aphria CEO says 'we are pleased with our second quarter results'
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 01/14/21
- Aurora Cannabis announces Canadian retail sales deal with Great North
- 01/06/21
- Aurora Cannabis rises 13.7%
- 01/06/21
- Aurora Cannabis rises 13.8%
- 12/16/20
- Aurora Cannabis provides business update, closing Aurora Sun facility
- 01/05/21
- CV Sciences launches ProCBD product line
- 12/08/20
- CV Sciences enters common stock purchase agreement with Tumim Stone
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 11/04/20
- CV Sciences launches PlusCBD pet product line
- 01/08/21
- CannTrust launches new medical brand, estora
- 12/02/20
- CannTrust returns to Canadian marketplace with two recreational brands
- 08/06/20
- CannTrust says licenses reinstated for Vaughan Manufacturing Facility
- 01/14/21
- Canopy Growth files early warning report regarding TerrAscend Corp.
- 01/07/21
- Constellation recognized $770M increase in fair value of Canopy investments
- 12/21/20
- Canopy Growth to have no interest in Canopy Rivers following Plan of Arrangement
- 12/21/20
- Canopy Growth announces plan of arrangement with Canopy Rivers
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 10/05/20
- Cronos Group launches PEACE NATURALS brand in Israel
- 09/09/20
- Cronos Group appoints Kurt Schmidt as CEO
- 01/04/21
- General Cannabis raises over $2.9M of senior convertible promissory notes
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 09/14/20
- General Cannabis appoints Diane Jones as CFO
- 01/14/21
- Aphria CEO says 'we are pleased with our second quarter results'
- 12/16/20
- Aphria, Tilray announce $3.9B combination
- 12/16/20
- Aphria, Tilray confirm merger agreement with implied equity value of C$5B
- 12/15/20
- Tilray up 8%, Aphria up 2% after merger speculation reported by Bloomberg
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 12/17/20
- Zynerba announces development plan for Zygel
- 12/17/20
- Zynerba provides regulatory update on Zygel in Fragile X syndrome
- 12/10/20
- Immunome appoints Richard Baron to board, Stoneman as Chief Legal Officer
- 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
IGC India Globalization Capital - 11/24/20
- Cannabis stocks soar as Trump approves start of transition to Biden
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 11/23/20
- IGC commences Phase 1 of cannabinoid trial for Alzheimer's patients
- 08/11/20
- India Globalization gets FDA approval to initiate cannabinoid formulation study
- 01/19/21 Stifel
- Aphria price target raised to $15.50 from $9.80 at Stifel
- 01/15/21 CIBC
- Aphria price target raised to C$18 from C$12.50 at CIBC
- 01/15/21 Alliance Global Partners
- Aphria price target raised to C$20 from C$12 at Alliance Global Partners
- 01/15/21 BMO Capital
- Aphria price target raised to C$15 from C$7 at BMO Capital
- 01/06/21 BMO Capital
- Federal cannabis reform in U.S. likely to take time, says BMO Capital
- 12/17/20 BMO Capital
- Aurora Cannabis downgraded to Underperform from Market Perform at BMO Capital
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 06/12/20 Cowen
- CV Sciences initiated with a Market Perform at Cowen
- 01/06/21 BMO Capital
- Federal cannabis reform in U.S. likely to take time, says BMO Capital
- 01/05/21 Cantor Fitzgerald
- Canopy Growth price target raised to C$33 from C$29 at Cantor Fitzgerald
- 12/28/20 JPMorgan
- Constellation Brands price target raised to $248 from $218 at JPMorgan
- 12/24/20 Raymond James
- Raymond James says Village Farms situated well for cannabis sector consolidation
- 01/06/21 BMO Capital
- Federal cannabis reform in U.S. likely to take time, says BMO Capital
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 11/16/20 Jefferies
- Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
- 01/15/21 Alliance Global Partners
- Aphria price target raised to C$20 from C$12 at Alliance Global Partners
- 01/15/21 BMO Capital
- Aphria price target raised to C$15 from C$7 at BMO Capital
- 12/24/20 Raymond James
- Raymond James says Village Farms situated well for cannabis sector consolidation
- 12/17/20 Canaccord
- Aphria downgraded to Hold from Speculative Buy at Canaccord
- 01/19/21 Needham
- Trulieve Cannabis price target raised to $60.50 from $36.25 at Needham
- 01/13/21 Canaccord
- Trulieve Cannabis price target raised to C$75 from C$60 at Canaccord
- 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 12/21/20 H.C. Wainwright
- Zynerba price target lowered to $9 from $12 at H.C. Wainwright
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 07/01/20 H.C. Wainwright
- Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
IGC India Globalization Capital - 12/04/20 Alliance Global Partners
- Alliance Global sees low odds of MORE Act passing this congressional session
- 12/02/20 Alliance Global Partners
- Alliance Global Partners sees UN cannabis reclassification helping legalization
- 08/31/20 Roth Capital
- Roth Capital believes MORE Act will not pass in 2020
- 04/08/20 Raymond James
- Ontario AG order positive for Canadian cannabis stocks, says Raymond James
- 01/14/21
- Aphria reports Q2 adjusted EPS C$0.01 vs. (C$0.19) a year ago
- 10/15/20
- Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 11/09/20
- Aurora Cannabis reports Q1 revenue C$67.8M vs. C$67.5M in Q4
- 10/30/20
- Aurora Cannabis sees Q1 revenue at high end of $60M-$64M previous guidance
- 09/22/20
- Aurora Cannabis sees Q1 revenue $60M-$64M vs. $67.5M in Q4
- 09/22/20
- Aurora Cannabis reports Q4 revenue $72.1M, a 5% decline from last quarter
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 01/07/21
- Constellation Brands reports Q3 adjusted EPS ex. Canopy $3.16, consensus $2.39
- 11/09/20
- Canopy Growth reports Q2 EPS (C$0.09) vs. C$0.25 last year
- 10/01/20
- Constellation Brands reports Q2 comparable EPS ex. Canopy Growth losses $2.91
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 11/05/20
- Cronos Group reports Q3 revenue $11.36M vs. $5.79M a year ago
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 08/06/20
- Cronos Group reports Q2 EPS (31c) vs. 16c last year
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 11/09/20
- Tilray sees positive or break even adjusted EBITDA in Q4
- 11/09/20
- Tilray reports Q3 EPS (2c), consensus (21c)
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 08/10/20
- Tilray reports Q2 EPS (66c), consensus (27c)
- 11/17/20
- Trulieve Cannabis reports Q3 EPS 15c
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 11/09/20
- Zynerba reports Q3 EPS (31c), consensus (43c)
- 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
- 08/10/20
- Zynerba reports Q2 EPS (78c), consensus (45c)
IGC India Globalization Capital - 08/26/20
- Vireo Health reports Q2 adjusted net loss $7.4M versus loss of $4.1M in Q219
|
On The Fly
| ShowHide Related Items >><< - 12/04/20
- Virgin Galactic unveils spacesuits developed in partnership with Under Armour
- 12/01/20
- Under Armour announces creation and launch of Curry Brand
- 10/30/20
- Under Armour says has line of sight to deliver slightly positive EPS in 2021
- 10/30/20
- Under Armour to sell MyFitnessPal platform to Francisco Partners in $345M deal
- 12/04/20
- Virgin Galactic unveils spacesuits developed in partnership with Under Armour
- 12/01/20
- Under Armour announces creation and launch of Curry Brand
- 10/30/20
- Under Armour says has line of sight to deliver slightly positive EPS in 2021
- 10/30/20
- Under Armour to sell MyFitnessPal platform to Francisco Partners in $345M deal
- 06:21 Today Deutsche Bank
- Under Armour upgraded to Buy from Hold at Deutsche Bank
- 06:06 Today Deutsche Bank
- Under Armour upgraded to Buy from Hold at Deutsche Bank
- 01/15/21 B. Riley Securities
- Under Armour price target raised to $15 from $13 at B. Riley Securities
- 01/07/21 JPMorgan
- Under Armour price target raised to $19 from $17 at JPMorgan
- 06:21 Today Deutsche Bank
- Under Armour upgraded to Buy from Hold at Deutsche Bank
- 01/15/21 B. Riley Securities
- Under Armour price target raised to $15 from $13 at B. Riley Securities
- 01/07/21 JPMorgan
- Under Armour price target raised to $19 from $17 at JPMorgan
- 01/04/21 Pivotal Research
- Under Armour upgraded to Buy from Hold at Pivotal Research
- 10/30/20
- Under Armour sees FY20 adj. EPS (49c)-(47c), consensus (72c)
- 10/30/20
- Under Armour sees Q4 revenue down low-teen percentage rate, consensus $1.12B
- 10/30/20
- Under Armour reports Q3 adj. EPS 26c, consensus 3c
- 10/29/20
- Notable companies reporting before tomorrow's open
- 10/30/20
- Under Armour sees FY20 adj. EPS (49c)-(47c), consensus (72c)
- 10/30/20
- Under Armour sees Q4 revenue down low-teen percentage rate, consensus $1.12B
- 10/30/20
- Under Armour reports Q3 adj. EPS 26c, consensus 3c
- 10/29/20
- Notable companies reporting before tomorrow's open
- 12/14/20
- Under Armour sued over 'infrared' claims about workout wear, Bloomberg reports
- 12/01/20
- Under Armour, NBA's Steph Curry to launch 'Curry Brand,' NY Post reports
- 10/22/20
- Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear
- 08/27/20
- Under Armour sued by UCLA for pulling out of apparel deal, LA Times reports
- 12/14/20
- Under Armour sued over 'infrared' claims about workout wear, Bloomberg reports
- 12/01/20
- Under Armour, NBA's Steph Curry to launch 'Curry Brand,' NY Post reports
- 10/22/20
- Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear
- 08/27/20
- Under Armour sued by UCLA for pulling out of apparel deal, LA Times reports
- 11/18/20
- Tesla, Boeing upgrades among today's top calls on Wall Street
- 11/17/20
- American initiation, Moderna downgrade among today's top calls on Wall Street
- 11/12/20
- Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street
- 11/02/20
- Intel, Cardinal Health upgrades among today's top calls on Wall Street
- 11/18/20
- Tesla, Boeing upgrades among today's top calls on Wall Street
- 11/17/20
- American initiation, Moderna downgrade among today's top calls on Wall Street
- 11/12/20
- Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street
- 11/02/20
- Intel, Cardinal Health upgrades among today's top calls on Wall Street
- 09:40 Today
- Unusually active option classes on open January 21st
- 07:35 Today
- Unusual call flow in option market yesterday
- 01/20/21
- Bull tries on $2M worth of Under Armour March 20 calls
- 12/08/20
- Unusual call flow in option market yesterday
- 12/01/20
- Under Armour call volume above normal and directionally bullish
- 11/16/20
- Under Armour call volume above normal and directionally bullish
- 11/12/20
- Under Armour call volume above normal and directionally bullish
- 10/30/20
- Early notable gainers among liquid option names on October 30th
|